Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03373487
Other study ID # 842003009
Secondary ID
Status Recruiting
Phase N/A
First received September 5, 2017
Last updated February 12, 2018
Start date July 1, 2015
Est. completion date June 30, 2019

Study information

Verified date October 2017
Source Elisabeth-TweeSteden Ziekenhuis
Contact Karin Gehring, PhD
Phone +314664233
Email k.gehring@uvt.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Many patients with primary brain tumors experience cognitive deficits and cognitive rehabilitation programs aim to alleviate these deficits.The cognitive rehabilitation program developed by the investigators proved effective in a large randomized controlled trial (RCT). To increase its accessibility, it was converted into the iPad-based cognitive rehabilitation program ReMind, which incorporates psychoeducation, strategy training and retraining. A pilot study and a randomized controlled trial are conducted, to evaluate the feasibility of the use of the program and the efficacy of the program in brain tumor patients after resective surgery.


Description:

OBJECTIVE: To evaluate the immediate and longer-term effects of early cognitive telerehabilitation on cognitive performance and self-reported symptoms/functioning in patients with low-grade gliomas and meningiomas, in a prospective randomized trial.

HYPOTHESIS: Cognitive telerehabilitation after brain tumor surgery has both immediate and longer-term beneficiary effects on cognitive functioning and patient-reported outcomes.

STUDY DESIGN: In the first 6 months of the project a feasibility study will be conducted to ensure that adherence, patient experience, and potential attrition are acceptable.

Subsequently, a prospective randomized (waiting-list) controlled trial (RCT) will be performed. Information from the feasibility study will be used to modify the RCT when necessary. In the RCT, patients are randomized to early cognitive rehabilitation (3 months after surgery) or to a waiting-list control condition. The waiting-list control group will be offered the same cognitive rehabilitation program after they have undergone all study assessments. Assessment of cognitive performance and self-reported symptoms will be performed prior to surgery (T0), before cognitive rehabilitation (3 months after surgery, T3), immediately after cognitive rehabilitation (6 months after surgery, T6), and at half-year follow up (12 months after surgery, T12).

STUDY POPULATION/SAMPLE SIZE: Patients with presumed low-grade glioma or meningioma, who are scheduled for resective surgery, will be included in the study. Fifteen patients will be invited in feasibility study. Based on the yearly numbers of meningioma and low-grade glioma patients that are operated in the Elisabeth-TweeSteden Hospital Tilburg, it is expected that 60 patients will be randomized in the RCT per year for 2.5 years. With a maximum attrition rate of 33%, a minimum of 100 patients (50 per group) will be evaluated.

INTERVENTION: An evidence-based cognitive rehabilitation program that is provided via a tablet app. The program consists of retraining, and teaching and practicing of compensational strategies of attention, memory and executive functioning. Patients spend 3 hours per week during 2.5 month in this home-based program. They are monitored and supervised by a trainer.

OUTCOME MEASURES: Feasibility (accrual, attrition, adherence, patient experience) will be monitored in the feasibility study.

At several time points during the RCT, patients will be tested with the computerized test battery (for cognition; CNS VS), two additional cognitive tests and several self-report questionnaires. Testing is done prior to surgery, prior to cognitive rehabilitation (3 months), immediately after cognitive rehabilitation (6 months) and at half-year follow up (12 months post-surgery). Questionnaires on self-reported cognitive functioning, psychological symptoms (anxiety and depression), and fatigue will be administered on all assessments; the questionnaires on work status, professional functioning and community integration are administered at baseline and one-year follow-up only.


Recruitment information / eligibility

Status Recruiting
Enrollment 115
Est. completion date June 30, 2019
Est. primary completion date June 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The adult patient has a (supratentorial or infratentorial) brain tumor that is radiologically suspect for either a meningioma or low grade glioma

- The patient will undergo resective surgery for the brain tumor

Exclusion Criteria:

- tumor resection in the last year

- progressive neurological disease

- diagnose of (acute) psychiatric or neurological disorders in the last 2 years

- chemotherapy in the last 2 years

- Karnovsky Performance Scale under 70

- Surgery-related complication (morbidity or mortality e.g., thrombosis or heart attack)

- Lack of basic proficiency in Dutch

- IQ below 85, or (very) low cognitive skills

- Insufficient reading skills/visual impairment (limiting the ability to follow the cognitive rehabilitation program).

- Clinical referral to cognitive rehabilitation

Study Design


Intervention

Behavioral:
The cognitive rehabilitation program ReMind
Cognitive rehabilitation, i.e. psychoeducation, strategy training & retraining

Locations

Country Name City State
Netherlands Erasmus Medical Center Rotterdam
Netherlands Medical Center Haaglanden The Hague
Netherlands Elisabeth-TweeSteden Hospital Tilburg

Sponsors (5)

Lead Sponsor Collaborator
Elisabeth-TweeSteden Ziekenhuis Erasmus Medical Center, Medical Center Haaglanden, University of Tilburg, ZonMw: The Netherlands Organisation for Health Research and Development

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in objective cognitive functioning Objective cognitive functioning is measured with the computerized test battery CNS Vital Signs 3, 6, and 12 months after surgery
Primary Change in working memory Working memory is measured with the subtest Digit Span of the the Wechsler Adult Intelligence Scale (WAIS-III) 3, 6, and 12 months after surgery
Primary Change in word fluency Word fluency is measured with the Letter Fluency test 3, 6, and 12 months after surgery
Secondary Change in subjective cognitive functioning Subjective cognitive functioning is measured with the Cognitive Failures Questionnaire (CFQ) 3, 6, and 12 months after surgery
Secondary Change in symptoms of fatigue Fatigue is measured with the Multidimensional Fatigue Inventory (MFI) 3, 6, and 12 months after surgery
Secondary Change in symptoms of anxiety Anxiety is measured with the Hospital Anxiety and Depression Scale (HADS) 3, 6, and 12 months after surgery
Secondary Change in symptoms of depression Depression is measured with the Hospital Anxiety and Depression Scale (HADS) 3, 6, and 12 months after surgery
Secondary Change in subjective executive functioning Subjective executive functioning is measured with the Behavior Rating Inventory of Executive Function 3, 6, and 12 months after surgery
Secondary Change in professional functioning (1) Professional functioning is measured with the Work Ability Index (WAI) One day before surgery vs. 12 months after surgery
Secondary Change in professional functioning (2) Professional functioning is measured with the Work Limitation Questionnaire (WLQ) One day before surgery vs. 12 months after surgery
Secondary Change in (social) participation Participation is measured with the Community Integration Questionnaire (CIQ) One day before surgery vs. 12 months after surgery
See also
  Status Clinical Trial Phase
Completed NCT02122198 - Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women N/A
Recruiting NCT04356924 - Psychological Treatment to Support the Consequences of Cognitive Impairment N/A
Suspended NCT05542238 - The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury N/A
Terminated NCT04493957 - Evaluation of an Educational Program in the Prevention of the Driving Risks in Patients With Neurocognitive Disorders : ACCOMPAGNE N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Not yet recruiting NCT05068323 - Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients N/A
Completed NCT04426838 - Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad N/A
Completed NCT04713384 - Remote Bimanual Virtual Rehabilitation Post CVD N/A
Recruiting NCT06284213 - Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
Recruiting NCT06053775 - Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP) N/A
Completed NCT03698695 - A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers Phase 1
Not yet recruiting NCT05552729 - Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors Phase 1/Phase 2
Recruiting NCT03268109 - COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
Completed NCT03187353 - IMProving Executive Function Study Phase 4
Completed NCT03301402 - Air Purifier to Improve Endothelial Function and Carotid Intima Thickness N/A
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Recruiting NCT04897334 - Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke N/A
Recruiting NCT04907565 - Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue
Recruiting NCT05030285 - Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment N/A